Metsera, Inc. presents four studies on GLP-1 receptor agonist MET-097i at the ADA conference, showcasing clinical and preclinical data. Metsera, Inc., a biopharmaceutical company focused on obesity ...
Company to host conference call and webcast today at 8:00 A.M. ET NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (MTSR), today announced positive topline data from the Phase 1 clinical ...
The Met Office and Microsoft are deepening their partnership with the release of two significant Met Office datasets, UK deterministic (2km) and global deterministic (10km), on the Microsoft Planetary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results